02150nam 2200421z- 450 991026114000332120231214133221.0(CKB)4100000002484692(oapen)https://directory.doabooks.org/handle/20.500.12854/54524(EXLCZ)99410000000248469220202102d2017 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierNeuropeptides and Behaviour: From Motivation to PsychopathologyFrontiers Media SA20171 electronic resource (146 p.)Frontiers Research Topics2-88945-307-3 The discovery of the involvement of neuropeptides with behaviours other than regulatory motivated ones took place in the midst of 1960’s with David de Wied’s first report on the influence of pituitary peptides on memory. This major scientific breakthrough opened a new frontier of studies in Endocrinology and its related fields, Neuroendocrinology and Psychoneuroendocrinology. Neuropeptides were initially thought to be involved in homeostatic regulation and secreted only from neurons located in the hypothalamus; they are now recognized neurotransmitters, produced in and secreted from distinct brain areas, associated with a myriad of, not only, motivated, but also psychopathological behaviours. Motivated behaviours are determinant for individual and species survival, but their expression in a large spectrum and deviations from average may give rise to a number of psychiatric conditions.Neuropeptides and Behaviourdrug adictionsleepstressanxietystress resilienceNeuropeptidesadaptive behavioursfeeding behaviourdepressionCarol F. Eliasauth1277578Deborah SucheckiauthBOOK9910261140003321Neuropeptides and Behaviour: From Motivation to Psychopathology3011660UNINA